<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37655084</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2075-0528</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Sultan Qaboos University medical journal</Title><ISOAbbreviation>Sultan Qaboos Univ Med J</ISOAbbreviation></Journal><ArticleTitle>Machine Learning Approach for Predicting Systemic Lupus Erythematosus in an Oman-Based Cohort.</ArticleTitle><Pagination><StartPage>328</StartPage><EndPage>335</EndPage><MedlinePgn>328-335</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18295/squmj.12.2022.069</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study aimed to design a machine learning-based prediction framework to predict the presence or absence of systemic lupus erythematosus (SLE) in a cohort of Omani patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Data of 219 patients from 2006 to 2019 were extracted from Sultan Qaboos University Hospital's electronic records. Among these, 138 patients had SLE, while the remaining 81 had other rheumatologic diseases. Clinical and demographic features were analysed to focus on the early stages of the disease. Recursive feature selection was implemented to choose the most informative features. The CatBoost classification algorithm was utilised to predict SLE, and the SHAP explainer algorithm was applied on top of the CatBoost model to provide individual prediction reasoning, which was then validated by rheumatologists.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">CatBoost achieved an area under the receiver operating characteristic curve score of 0.95 and a sensitivity of 92%. The SHAP algorithm identified four clinical features (alopecia, renal disorders, acute cutaneous lupus and haemolytic anaemia) and the patient's age as having the greatest contribution to the prediction.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">An explainable framework to predict SLE in patients and provide reasoning for its prediction was designed and validated. This framework enables clinicians to implement early interventions that will lead to positive healthcare outcomes.</AbstractText><CopyrightInformation>&#xa9; Copyright 2023, Sultan Qaboos University Medical Journal, All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>AlShareedah</LastName><ForeName>AlHassan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Sultan Qaboos University, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zidoum</LastName><ForeName>Hamza</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Sultan Qaboos University, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sawafi</LastName><ForeName>Sumaya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Sultan Qaboos University, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Lawati</LastName><ForeName>Batool</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, College of Medicine, Sultan Qaboos University, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ansari</LastName><ForeName>Aliya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology, College of Science, Sultan Qaboos University, Muscat, Oman.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Oman</Country><MedlineTA>Sultan Qaboos Univ Med J</MedlineTA><NlmUniqueID>101519915</NlmUniqueID><ISSNLinking>2075-051X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009850" MajorTopicYN="N" Type="Geographic">Oman</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000505" MajorTopicYN="N">Alopecia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Decision Support System</Keyword><Keyword MajorTopicYN="N">Data Analysis</Keyword><Keyword MajorTopicYN="N">Interpretation</Keyword><Keyword MajorTopicYN="N">Oman</Keyword><Keyword MajorTopicYN="N">Statistical Data</Keyword><Keyword MajorTopicYN="N">Supervised Machine Learning</Keyword><Keyword MajorTopicYN="N">Systemic Lupus Erythematosus</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37655084</ArticleId><ArticleId IdType="pmc">PMC10467556</ArticleId><ArticleId IdType="doi">10.18295/squmj.12.2022.069</ArticleId><ArticleId IdType="pii">squmj2308-328-335</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gaipl U, Munoz L, Grossmayer G, Lauber K, Franz S, Sarter K, et al. Clearance deficiency and systemic lupus erythematosus (SLE) J Autoimmun. 2007;28:114&#x2013;21. doi: 10.1016/j.jaut.2007.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2007.02.005</ArticleId><ArticleId IdType="pubmed">17368845</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisengard R. Diagnosis of systemic lupus erythematosus. Importance of antinuclear antibody titers and peripheral staining patterns. Arch Dermatol. 1975;111:1298&#x2013;300. doi: 10.1001/archderm.111.10.1298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archderm.111.10.1298</ArticleId><ArticleId IdType="pubmed">54050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis M, Jawad A. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford) 2016. p. kew399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew399</ArticleId><ArticleId IdType="pubmed">27940583</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Adhoubi N, Al-Balushi F, Al Salmi I, Ali M, Al Lawati T, Al Lawati B, et al. A multicenter longitudinal study of the prevalence and mortality rate of systemic lupus erythematosus patients in Oman: Oman lupus study. Int J Rheum Dis. 2021;24:847&#x2013;54. doi: 10.1111/1756-185x.14130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185x.14130</ArticleId><ArticleId IdType="pubmed">34058079</ArticleId></ArticleIdList></Reference><Reference><Citation>Felten R, Lipsker D, Sibilia J, Chasset F, Arnaud L. The history of lupus throughout the ages. J Am Acad Dermatol. 2022;87:1361&#x2013;9. doi: 10.1016/j.jaad.2020.04.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.04.150</ArticleId><ArticleId IdType="pubmed">32380218</ArticleId></ArticleIdList></Reference><Reference><Citation>Piga M, Arnaud L. The main challenges in systemic lupus erythematosus: Where do we stand? J Clin Med. 2021;10:243. doi: 10.3390/jcm10020243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10020243</ArticleId><ArticleId IdType="pmc">PMC7827672</ArticleId><ArticleId IdType="pubmed">33440874</ArticleId></ArticleIdList></Reference><Reference><Citation>Oglesby A, Korves C, Lalibert&#xe9; F, Dennis G, Rao S, Suthoff E, et al. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes. Appl Health Econ Health Policy. 2014;12:179&#x2013;90. doi: 10.1007/s40258-014-0085-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40258-014-0085-x</ArticleId><ArticleId IdType="pubmed">24573911</ArticleId></ArticleIdList></Reference><Reference><Citation>Murimi-Worstell I, Lin D, Nab H, Kan H, Onasanya O, Tierce J, et al. Association between organ damage and mortality in systemic lupus erythematosus: A systematic review and meta-analysis. BMJ Open. 2020;10:e031850. doi: 10.1136/bmjopen-2019-031850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-031850</ArticleId><ArticleId IdType="pmc">PMC7247371</ArticleId><ArticleId IdType="pubmed">32444429</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Brinks R, D&#xf6;rner T, Daikh D, Mosca M, Ramsey-Goldman R, et al. European league against rheumatism (EULAR)/American college of rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021;80:775&#x2013;81. doi: 10.1136/annrheumdis-2020-219373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219373</ArticleId><ArticleId IdType="pubmed">33568386</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorogush A, Ershov V, Gulin A.CatBoost: Gradient boosting with categorical features support arXiv [Pre-print] 201810.48550/arXiv.1810.11363.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1810.11363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg SM, Lee SI. A unified approach to interpreting model predictions. 31st International Conference on Neural Information Processing Systems. Adv Neural Inf Process Syst. 2017;30:4768&#x2013;77.</Citation></Reference><Reference><Citation>Adamichou C, Genitsaridi I, Nikolopoulos D, Nikoloudaki M, Repa A, Bortoluzzi A, et al. Lupus or not? SLE risk probability index (SLERPI): A simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Ann Rheum Dis. 2021;80:758&#x2013;66. doi: 10.1136/annrheumdis-2020-219069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219069</ArticleId><ArticleId IdType="pmc">PMC8142436</ArticleId><ArticleId IdType="pubmed">33568388</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalband S, Sundar A, Prince A, Agarwal A. Feature selection and classification methodology for the detection of knee-joint disorders. Comput Methods Programs Biomed. 2016;127:94&#x2013;104. doi: 10.1016/j.cmpb.2016.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2016.01.020</ArticleId><ArticleId IdType="pubmed">27000292</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro SGK, Sahu KK.Normalization: A preprocessing stage arXiv [Pre-print] 201510.48550/ARXIV.1503.06462.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/ARXIV.1503.06462</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiglic G, Kocbek P, Fijacko N, Zitnik M, Verbert K, Cilar L. Interpretability of machine learning-based prediction models in healthcare. Wiley Interdiscip Rev Data Min Knowl Discov. 2020;10:e1379. doi: 10.1002/widm.1379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/widm.1379</ArticleId></ArticleIdList></Reference><Reference><Citation>Binder A, Ellis S. When to order an antinuclear antibody test. BMJ. 2013;347:f5060. doi: 10.1136/bmj.f5060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f5060</ArticleId><ArticleId IdType="pubmed">23965507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichainun R. Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: A comparison using control sera obtained from healthy individuals and patients with multiple medical problems. Asian Pac J Allergy Immunol. 2013;31:292&#x2013;8. doi: 10.12932/AP0272.31.4.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP0272.31.4.2013</ArticleId><ArticleId IdType="pubmed">24383972</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnaud L, Mathian A, Boddaert J, Amoura Z. Late-onset systemic lupus erythematosus. Drugs Aging. 2012;29:181&#x2013;9. doi: 10.3899/jrheum.080957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.080957</ArticleId><ArticleId IdType="pubmed">22263748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalani S, Pope J, de Leon F, Peschken C. Clinical features and prognosis of late-onset systemic lupus erythematosus: Results from the 1000 faces of lupus study. J Rheumatol. 2009;37:38&#x2013;44. doi: 10.3899/jrheum.080957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.080957</ArticleId><ArticleId IdType="pubmed">20008925</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckwith H, Lightstone L. Rituximab in systemic lupus erythematosus and lupus nephritis. Nephron Clin Pract. 2014;128:250&#x2013;4. doi: 10.1159/000368585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000368585</ArticleId><ArticleId IdType="pubmed">25471633</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A, Amelio J, Gairy K, Kaur G, Levy R, Roth D, et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: A pragmatic review mapping disease severity and progression. Lupus. 2020;29:1011&#x2013;20. doi: 10.1177/0961203320932219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320932219</ArticleId><ArticleId IdType="pmc">PMC7425376</ArticleId><ArticleId IdType="pubmed">32571142</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021;11:928. doi: 10.3390/biom11070928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11070928</ArticleId><ArticleId IdType="pmc">PMC8301935</ArticleId><ArticleId IdType="pubmed">34206696</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannouli S. Anaemia in systemic lupus erythematosus: From pathophysiology to clinical assessment. Ann Rheum Dis. 2006;65:144&#x2013;8. doi: 10.1136/ard.2005.041673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2005.041673</ArticleId><ArticleId IdType="pmc">PMC1798007</ArticleId><ArticleId IdType="pubmed">16079164</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Arfaj A, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus. 2009;18:465&#x2013;73. doi: 10.1177/0961203308100660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308100660</ArticleId><ArticleId IdType="pubmed">19318403</ArticleId></ArticleIdList></Reference><Reference><Citation>AlSaleh J, Jassim V, ElSayed M, Saleh N, Harb D. Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus. 2008;17:62&#x2013;6. doi: 10.1177/0961203307084297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203307084297</ArticleId><ArticleId IdType="pubmed">18089686</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hadidi K, Medhat B, Abdel Baki N, Abdel Kafy H, Abdelrahaman W, Yousri A, et al. Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: A retrospective cohort of 1109 patients from a single center. Lupus. 2018;27:1030&#x2013;8. doi: 10.1177/0961203317751856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317751856</ArticleId><ArticleId IdType="pubmed">29431056</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Rasbi A, Abdalla E, Sultan R, Abdullah N, Al Kaabi J, Al-Zakwani I, et al. Spectrum of systemic lupus erythematosus in Oman: From childhood to adulthood. Rheumatol Int. 2018;38:1691&#x2013;8. doi: 10.1007/s00296-018-4032-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-018-4032-2</ArticleId><ArticleId IdType="pubmed">29721697</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shujairi A, Elbadawi F, Al-Saleh J, Hamouda M, Vasylyev A, Khamashta M. Literature review of lupus nephritis from the Arabian Gulf region. Lupus. 2023;32:155&#x2013;65. doi: 10.1177/09612033221137248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221137248</ArticleId><ArticleId IdType="pmc">PMC9810828</ArticleId><ArticleId IdType="pubmed">36331103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hancock J, Khoshgoftaar T. CatBoost for big data: An inter-disciplinary review. J Big Data. 2020;7:94. doi: 10.1186/s40537-020-00369-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40537-020-00369-8</ArticleId><ArticleId IdType="pmc">PMC7610170</ArticleId><ArticleId IdType="pubmed">33169094</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokhorenkova L, Gusev G, Vorobev A, Dorogush A, Gulin A. CatBoost: Unbiased boosting with categorical features. arXiv [Pre-print] 2017. p. 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1706.09516</ArticleId></ArticleIdList></Reference><Reference><Citation>Anghel A, Papandreou N, Parnell T, De Palma A, Pozidis H.Benchmarking and optimization of gradient boosting decision tree algorithms arXiv [Pre-print] 20183.10.48550/arXiv.1809.04559.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1809.04559</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco P, Torgo L, Ribeiro R. A survey of predictive modeling on imbalanced domains. ACM Comput Surv. 2016;49:1&#x2013;50. doi: 10.1145/2907070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2907070</ArticleId></ArticleIdList></Reference><Reference><Citation>Pargent F, Pfisterer F, Thomas J, Bischl B. Regularized target encoding outperforms traditional methods in supervised machine learning with high cardinality features. Comput Stat. 2022;37:2671&#x2013;92. doi: 10.1007/s00180-022-01207-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00180-022-01207-6</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>